Cipla Ltd.
| BSE: 500087 | Sector: Health care |
| NSE: CIPLA | ISIN Code: INE059A01026 |
| BSE 00:00 | 01 Jul | 950.10 |
34.90 (3.81%) |
OPEN
915.00 |
HIGH
955.75 |
LOW
914.35 |
| NSE 00:00 | 01 Jul | 949.30 |
32.10 (3.50%) |
OPEN
911.20 |
HIGH
956.05 |
LOW
911.20 |
| OPEN | 915.00 |
| PREVIOUS CLOSE | 915.20 |
| VOLUME | 29812 |
| 52-Week high | 1083.15 |
| 52-Week low | 850.00 |
| P/E | 25.92 |
| Mkt Cap.(Rs cr) | 76,664 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Cipla Ltd. (CIPLA) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 826.70 | -0.49 | 966.90 | 664.10 | 198350.12 |
| Divi's Lab. | 3634.80 | 0.10 | 5425.00 | 3365.10 | 96485.77 |
| Cipla | 950.10 | 3.81 | 1083.15 | 850.00 | 76663.57 |
| Dr Reddy's Labs | 4384.35 | -0.35 | 5613.65 | 3655.00 | 72973.12 |
| Apollo Hospitals | 3735.15 | 1.50 | 5930.70 | 3365.90 | 53703.99 |
| Torrent Pharma. | 2915.00 | 1.94 | 3304.45 | 2485.00 | 49327.63 |
| Gland Pharma | 2655.90 | -1.70 | 4350.00 | 2498.00 | 43742.67 |
| Abbott India | 19081.95 | 1.57 | 23902.30 | 15525.00 | 40549.14 |
| Piramal Enterp. | 1670.35 | 0.70 | 3013.00 | 1561.00 | 39862.90 |
| Biocon | 311.65 | 1.20 | 414.30 | 305.00 | 37416.70 |
| Zydus Lifesci. | 362.10 | 1.50 | 655.00 | 319.40 | 37068.18 |
| Alkem Lab | 3020.25 | 0.64 | 4067.70 | 2835.00 | 36107.09 |
| Max Healthcare | 359.65 | -2.19 | 472.60 | 251.00 | 34872.74 |
| Aurobindo Pharma | 522.55 | 1.70 | 1012.90 | 503.40 | 30616.20 |
| Lupin | 628.55 | 2.81 | 1193.00 | 583.05 | 28573.88 |
| Glaxosmi. Pharma | 1503.35 | 0.24 | 1917.00 | 1433.05 | 25468.25 |
| Laurus Labs | 466.25 | 0.38 | 723.55 | 433.20 | 25053.94 |
| Ipca Labs. | 912.90 | 2.35 | 1383.55 | 831.40 | 23160.27 |
| Syngene Intl. | 561.00 | 0.84 | 699.95 | 508.10 | 22520.22 |
| Pfizer | 4112.75 | 0.61 | 6164.80 | 4056.00 | 18815.83 |
Quick Links for Cipla:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
